ACTIVE SUBSTANCE / INN

PALONOSETRON HYDROCHLORIDE

Brand name(s): ALOXI, AKYNZEO, POSFREA, PALONOSETRON HYDROCHLORIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA210493
NDA021372
ACTIVE SUBSTANCE
Palonosetron Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
CIPLA, HELSINN HLTHCARE, AKORN INC
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PALONOSETRON HYDROCHLORIDEANDA206396CIPLADiscontinued
PALONOSETRON HYDROCHLORIDEANDA206801FRESENIUS KABI USAPrescription
AKYNZEONDA210493HELSINN HLTHCAREPrescription
AKYNZEONDA210493HELSINN HLTHCAREDiscontinued
ALOXINDA021372HELSINN HLTHCAREDiscontinued
POSFREANDA203050AVYXA HOLDINGSDiscontinued
POSFREANDA203050AVYXA HOLDINGSPrescription
PALONOSETRON HYDROCHLORIDEANDA204731AKORN INCNone (Tentative Approval)

FULL INTELLIGENCE ON PALONOSETRON HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →